Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Bolt-on acquisitions boost H1 results at Mpac, shares jump

(Sharecast News) - Mpac swung to a statutory loss in the first half due to restructuring charges, but shares rose strongly on Tuesday after the packaging and automation solutions company reported a big improvement in underlying results, along with the appointment of three new business veterans to the board. Revenues surged 41.2% year-on-year to £84.7m in the six months to 30 June, as acquisitions made during the second half of last year made a material contribution to the top line, offsetting lower revenues from existing businesses due to tariff-related uncertainty.

Mpac made three significant acquisitions during 2024 - Netherlands-based CSi Palletising, US outfit Boston Conveyor & Automation and UK-based SIGA Vision - all of which are "performing well and in line with expectations", the company said.

The company closed the period with an order book of £91.7m, up 18.3% on last year, with acquired businesses contributing £26.5m, while existing business units saw a 36.9% reduction in order intake to £37.7m.

Underlying pre-tax profit was up 25% at £5.0m. However, after taking a £11.5m hit from consolidating its operational footprint in the US to mitigate the impact of trade tariffs, falling consumer confidence and macro uncertainty - which saw customers defer capital investment decisions - the company reported a statutory pre-tax loss of £9.4m, compared with a £3.3m profit a year earlier.

"The proactive steps that we announced in July to accelerate the consolidation of our operational footprint in the US and to simplify our business in response to challenging conditions sets a direction of travel that will position the Group for future growth when markets fully recover," said chief executive Adam Holland.

Mpac also announced on Tuesday a trio of new veterans appointed to the board: Kier Group CFO Simon Kesterton, Senior CEO David Squires and De La Rue non-exec chair Clive Whiley have all been appointed as independent non-exec directors.

"Collectively and individually these appointments bring a wealth of experience in listed companies operating in many different countries and business environments," said Mpac chair Andrew Kitchingman. "All are highly respected business leaders with proven track records and will provide a wealth of experience to support Mpac in delivering future growth."

Shares were up 7.4% at 314p by 1150 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.